Spironolactone Tablet, Coated
Product Images NDC 72789-291

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72789-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

72789291 Label (72789291)

72789291 Label (72789291)
This is a description of a medication called Spironolactone USP 50 mg presented in a tablet form. The packaging advises that this medication should be kept out of reach of children. The recommended dosage for the medication is not available in the given text; the user should consult accompanying prescribing information. The tablet container used is light-resistant and child-resistant. The medication is stored ideally at 20-25°C (68-77°F), in a controlled room temperature environment. The accompanying information indicates that the medication is manufactured by Oxford Pharmaceuticals, LLC in Birmingham, Alabama, and marketed and packaged by PD-Rx Pharmaceuticals, Inc. The packaging is a bottle with a total of 90 tablets. The given scan also includes a lot number (K22861), an expiration date (05/2023), a serial number (00372789291901).*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.